Case report highlights anticoagulation strategies for phlegmasia cerulea dolens in ischemic stroke patients, suggesting delayed treatment may help reduce risks.
The purpose of this case report is to highlight anticoagulation management of phlegmasia cerulea dolens, particularly in a patient with a recent ischemic stroke that underwent hemorrhagic transformation. In select cases, delayed anticoagulation after appropriate neurological clearance can be a viable approach to prevent thrombotic progression while minimizing hemorrhagic risk.
No takes yet. Share an insight, caveat, or question.
Sarsour et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: